3,341 Shares in Prestige Consumer Healthcare Inc. $PBH Bought by Wealth Alliance LLC

Wealth Alliance LLC acquired a new stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 3,341 shares of the company’s stock, valued at approximately $267,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Cerity Partners LLC grew its holdings in shares of Prestige Consumer Healthcare by 3.7% during the first quarter. Cerity Partners LLC now owns 3,666 shares of the company’s stock worth $315,000 after buying an additional 132 shares during the last quarter. UMB Bank n.a. lifted its position in Prestige Consumer Healthcare by 81.8% during the 2nd quarter. UMB Bank n.a. now owns 320 shares of the company’s stock worth $26,000 after acquiring an additional 144 shares during the period. Bank of Montreal Can grew its stake in shares of Prestige Consumer Healthcare by 2.0% in the 2nd quarter. Bank of Montreal Can now owns 9,351 shares of the company’s stock valued at $747,000 after purchasing an additional 182 shares during the last quarter. Xponance Inc. grew its stake in shares of Prestige Consumer Healthcare by 5.5% in the 1st quarter. Xponance Inc. now owns 3,766 shares of the company’s stock valued at $324,000 after purchasing an additional 196 shares during the last quarter. Finally, Resona Asset Management Co. Ltd. raised its stake in shares of Prestige Consumer Healthcare by 2.3% during the first quarter. Resona Asset Management Co. Ltd. now owns 9,105 shares of the company’s stock worth $783,000 after purchasing an additional 203 shares during the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently weighed in on PBH shares. Oppenheimer decreased their price target on Prestige Consumer Healthcare from $82.00 to $72.00 and set an “outperform” rating for the company in a report on Tuesday, October 21st. Zacks Research raised shares of Prestige Consumer Healthcare from a “strong sell” rating to a “hold” rating in a report on Monday. Sidoti upgraded shares of Prestige Consumer Healthcare from a “neutral” rating to a “buy” rating and set a $80.00 price target on the stock in a research note on Wednesday, September 24th. Wall Street Zen cut shares of Prestige Consumer Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, August 9th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Prestige Consumer Healthcare in a research report on Wednesday, October 8th. Four investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $85.33.

Prestige Consumer Healthcare Stock Performance

PBH opened at $59.84 on Friday. Prestige Consumer Healthcare Inc. has a 1-year low of $59.18 and a 1-year high of $90.04. The stock has a market cap of $2.88 billion, a P/E ratio of 14.05, a P/E/G ratio of 1.93 and a beta of 0.41. The stock’s 50 day simple moving average is $62.44 and its 200 day simple moving average is $72.69. The company has a debt-to-equity ratio of 0.55, a current ratio of 4.38 and a quick ratio of 2.99.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, November 6th. The company reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $0.97 by $0.10. The company had revenue of $274.11 million for the quarter, compared to the consensus estimate of $257.14 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.Prestige Consumer Healthcare’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.09 earnings per share. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.540-4.580 EPS. As a group, equities analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.